Cillian King

Cillian King currently serves as Managing Director and Investment Manager at EQT Group since 2021. Additionally, Cillian holds board member positions at QurAlis, Muna Therapeutics, and Sairopa B.V., and is the founder of Koala Life Sciences. Previous roles include board membership at Pan Cancer T and Allero Therapeutics, where the focus was on developing advanced immunotherapies. Cillian's experience also encompasses investment management at Swanbridge Capital and a leadership role in life sciences at Catalyze. Cillian completed a PhD in Molecular Neurosciences at Vrije Universiteit Amsterdam and has served as a Research Fellow at the Massachusetts Institute of Technology (MIT).